Tilray Brands, Inc. Marketing and Advertising Expense
Tilray Brands, Inc. (TLRY) reported Marketing and Advertising Expense of $42.29 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2026-07-28
- Tilray Brands, Inc. marketing and advertising expense for the quarter ending 2026-05-31 was $13.46M, a 50.09% increase year-over-year.
- Tilray Brands, Inc. marketing and advertising expense for the quarter ending 2026-02-28 was $8.69M, a 27.96% increase year-over-year.
- Tilray Brands, Inc. marketing and advertising expense for the quarter ending 2025-11-30 was $9.98M, a 2.69% increase year-over-year.
- Tilray Brands, Inc. marketing and advertising expense for the quarter ending 2025-08-31 was $10.15M, a 12.20% decline year-over-year.
- Tilray Brands, Inc. marketing and advertising expense for fiscal 2026 was $42.29M, a 14.15% increase from fiscal 2025.
- Tilray Brands, Inc. marketing and advertising expense for fiscal 2025 was $37.05M, a 11.65% decline from fiscal 2024.
- Tilray Brands, Inc. marketing and advertising expense for fiscal 2024 was $41.93M, a 35.54% increase from fiscal 2023.
- Tilray Brands, Inc. marketing and advertising expense for fiscal 2023 was $30.94M, a 0.01% increase from fiscal 2022.
| Period end | Marketing and Advertising Expense 3 month | Marketing and Advertising Expense 6 month | Marketing and Advertising Expense 9 month | Marketing and Advertising Expense 12 month |
|---|---|---|---|---|
| 2026-05-31 | $13.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $22.15M derived: sum of 2 quarters · filed 2026-07-28 | $32.13M derived: sum of 3 quarters · filed 2026-07-28 | $42.29M 10-K · filed 2026-07-28 |
| 2026-02-28 | $8.69M 10-Q · filed 2026-04-01 | $18.67M derived: sum of 2 quarters · filed 2026-04-01 | $28.83M 10-Q · filed 2026-04-01 | $37.80M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $9.98M 10-Q · filed 2026-01-08 | $20.14M 10-Q · filed 2026-01-08 | $29.11M derived: sum of 3 quarters · filed 2026-07-28 | $35.90M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $10.15M 10-Q · filed 2025-10-09 | $19.12M derived: sum of 2 quarters · filed 2026-07-28 | $25.92M derived: sum of 3 quarters · filed 2026-07-28 | $35.64M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $8.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $15.76M derived: sum of 2 quarters · filed 2026-07-28 | $25.48M derived: sum of 3 quarters · filed 2026-07-28 | $37.05M 10-K · filed 2026-07-28 |
| 2025-02-28 | $6.79M 10-Q · filed 2026-04-01 | $16.51M derived: sum of 2 quarters · filed 2026-04-01 | $28.08M 10-Q · filed 2026-04-01 | $41.08M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $9.72M 10-Q · filed 2026-01-08 | $21.29M 10-Q · filed 2026-01-08 | $34.28M derived: sum of 3 quarters · filed 2026-07-28 | $45.48M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $11.57M 10-Q · filed 2025-10-09 | $24.57M derived: sum of 2 quarters · filed 2026-07-28 | $35.76M derived: sum of 3 quarters · filed 2026-07-28 | $44.96M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $24.19M derived: sum of 2 quarters · filed 2026-07-28 | $33.40M derived: sum of 3 quarters · filed 2026-07-28 | $41.93M 10-K · filed 2026-07-28 |
| 2024-02-29 | $11.19M 10-Q · filed 2025-04-08 | $20.40M derived: sum of 2 quarters · filed 2025-04-08 | $28.93M 10-Q · filed 2025-04-08 | $36.73M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $9.21M 10-Q · filed 2025-01-10 | $17.74M 10-Q · filed 2025-01-10 | $25.54M derived: sum of 3 quarters · filed 2025-07-29 | $32.90M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $8.54M 10-Q · filed 2024-10-10 | $16.34M derived: sum of 2 quarters · filed 2025-07-29 | $23.69M derived: sum of 3 quarters · filed 2025-07-29 | $32.22M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $15.15M derived: sum of 2 quarters · filed 2025-07-29 | $23.69M derived: sum of 3 quarters · filed 2025-07-29 | $30.94M 10-K · filed 2025-07-29 |
| 2023-02-28 | $7.35M 10-Q · filed 2024-04-09 | $15.89M derived: sum of 2 quarters · filed 2024-04-09 | $23.14M 10-Q · filed 2024-04-09 | $33.91M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $8.54M 10-Q · filed 2024-01-09 | $15.78M 10-Q · filed 2024-01-09 | $26.55M derived: sum of 3 quarters · filed 2024-10-10 | $34.13M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $7.25M 10-Q · filed 2024-10-10 | $18.02M derived: sum of 2 quarters · filed 2024-10-10 | $25.60M derived: sum of 3 quarters · filed 2024-10-10 | $32.72M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $10.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $18.35M derived: sum of 2 quarters · filed 2024-07-30 | $25.47M derived: sum of 3 quarters · filed 2024-07-30 | $30.93M 10-K · filed 2024-07-30 |
| 2022-02-28 | $7.58M 10-Q · filed 2023-04-10 | $14.70M derived: sum of 2 quarters · filed 2023-04-10 | $20.16M 10-Q · filed 2023-04-10 | $25.27M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | $7.12M 10-Q · filed 2023-01-09 | $12.59M 10-Q · filed 2023-01-09 | $17.69M derived: sum of 3 quarters · filed 2023-07-26 | $20.95M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $5.46M 10-Q · filed 2022-10-07 | $10.57M derived: sum of 2 quarters · filed 2023-07-26 | $13.83M derived: sum of 3 quarters · filed 2023-07-26 | $18.08M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-05-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $8.36M derived: sum of 2 quarters · filed 2023-07-26 | $12.61M derived: sum of 3 quarters · filed 2023-07-26 | $17.54M 10-K · filed 2023-07-26 |
| 2021-02-28 | $3.26M 10-Q · filed 2022-04-06 | $7.51M derived: sum of 2 quarters · filed 2022-04-06 | $12.44M 10-Q · filed 2022-04-06 | |
| 2020-11-30 | $4.25M 10-Q · filed 2022-01-10 | $9.18M 10-Q · filed 2022-01-10 | ||
| 2020-08-31 | $4.92M 10-Q · filed 2021-10-07 | |||
| 2020-05-31 | $15.27M 10-K · filed 2022-07-28 | |||
| 2019-05-31 | $17.40M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |